$GANX 4 SEC Filings

Filed On	Filing
17 Jul 2026	Form 4: Goldstein Dov A Md, Director Granted 25,000 Stock Option (right to buy)
17 Jul 2026	Form 4: Nicaise Claude, Director Granted 25,000 Stock Option (right to buy)
17 Jul 2026	Form 4: Islam Khalid, Director Granted 25,000 Stock Option (right to buy)
17 Jul 2026	Form 4: Melincoff Gwen A, Director Granted 25,000 Stock Option (right to buy)
17 Jul 2026	Form 4: Riley Jeffrey Scott, Director Granted 25,000 Stock Option (right to buy)
17 Jul 2026	Form 4: Hasler Hans Peter, Director Granted 25,000 Stock Option (right to buy)
26 Mar 2026	Form 4: Mack Gene, Director Granted 200,000 Employee Stock Option (right to buy)
26 Mar 2026	Form 4: Fuggetta Gianluca, See Remark Granted 50,000 Employee Stock Option (right to buy)
25 Jun 2025	Form 4: Islam Khalid, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Nicaise Claude, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Riley Jeffrey Scott, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Richman Eric I, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Hasler Hans Peter, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Goldstein Dov A Md, Director Granted 15,000 Stock Option (right to buy)
25 Jun 2025	Form 4: Melincoff Gwen A, Director Granted 15,000 Stock Option (right to buy)
21 Mar 2025	Form 4: Fuggetta Gianluca, See Remark Granted 50,000 Employee Stock Option (right to buy)
21 Mar 2025	Form 4: Mack Gene, Director Granted 200,000 Employee Stock Option (right to buy)
07 Jan 2025	Form 4: Mack Gene, Director Granted 271,325 Stock Option (right to buy)
12 Aug 2024	Form 4: Mack Gene, CFO and Interim CEO Bought 14,400 shares ($14.5K)
12 Aug 2024	Form 4: Islam Khalid, Director Bought 50,000 shares ($49.9K)

Comments